Skip to main content
Genome Medicine logoLink to Genome Medicine
. 2022 Feb 7;14:12. doi: 10.1186/s13073-022-01014-0

Correction to: Novel risk genes and mechanisms implicated by exome sequencing of 2572 individuals with pulmonary arterial hypertension

Na Zhu 1,2,#, Michael W Pauciulo 3,4,#, Carrie L Welch 1,#, Katie A Lutz 3, Anna W Coleman 3, Claudia Gonzaga-Jauregui 5, Jiayao Wang 1,2, Joseph M Grimes 1, Lisa J Martin 3,4, Hua He 3; PAH Biobank Enrolling Centers’ Investigators, Yufeng Shen 2,6,#, Wendy K Chung 1,7,8,#, William C Nichols 3,4,✉,#
PMCID: PMC8822702  PMID: 35130931

Correction to: Genome Med 11, 69 (2019)

https://doi.org/10.1186/s13073-019-0685-z

Following publication of the original article [1], two errors were identified in the Results section.

1. The sentence currently reads:

“For IPAH, we observed significant associations for BMPR2 (p = 1.0E − 7, FDR = 9.0E− 04), KLK1 (p = 1.0E− 7, FDR = 9.0E− 04), and GGCX (p = 5.0E− 07, FDR = 0.002) (see Fig. 4).

The sentence should read

“For IPAH, we observed significant associations for BMPR2 (p = 1.0E − 7, FDR = 9.0E− 04), KLK1 (p = 1.0E− 7, FDR = 9.0E− 04), and GGCX (p = 1.9E-06, FDR = 0.013).

Further down in the text:

2. The sentence currently reads:

“Likewise, while the association signal for GDF2 fell below the cutoff (p = 3.0E−07, FDR = 0.002), we clearly provide confirmation of this new PAH risk gene”.

The sentence should read:

“Likewise, while the association signal for GDF2 fell below the cutoff (p = 3.2E-06, FDR = 0.016), we clearly provide confirmation of this new PAH risk gene”.

The original article [1] has been corrected.

Footnotes

Na Zhu, Michael W. Pauciulo, Carrie L. Welch, Yufeng Shen, Wendy K. Chung and William C. Nichols contributed equally to this work.

Reference


Articles from Genome Medicine are provided here courtesy of BMC

RESOURCES